文献速递关节外科骨肿瘤

肿瘤性髋关节疾病对髋关节置换诊疗一体化费用的影响

To Bundle or Not to Bundle? The Financial Impact of Pathologic Hip Disease on Hip Arthroplasty Episodes of Care.
PubMed 文献 · J Arthroplasty · 2020-01-17

该回顾性研究比较了2014至2017年间因肿瘤性与非肿瘤性诊断行髋关节置换患者的诊疗一体化费用与结局,发现肿瘤组住院时间更长、再入院率更高、出院至专业护理机构比例更高,且各项费用均显著更高;多因素分析显示肿瘤诊断与费用增加独立相关,作者建议综合关节置换模型应纳入肿瘤疾病的风险调整。

要点

  • 肿瘤组住院时间显著长于非肿瘤组(7.2 vs 4.2天,P = .00)。
  • 肿瘤组再入院率(29% vs 14%,P = .05)和出院至专业护理机构比例(93% vs 51%,P = .00)更高。
  • 肿瘤诊断与诊疗一体化费用增加独立相关(β = 16,163 ± 2258,P = .00,r2 = 29%)。

核心结论

  • 肿瘤性诊断行髋关节置换的患者结局更差、费用更高,综合关节置换模型应纳入肿瘤疾病的风险调整。

研究设计与样本

  • 回顾性研究,从大型数据库收集2014至2017年因肿瘤性和非肿瘤性诊断行髋关节置换的患者数据。
  • 共纳入2122例患者,其中非肿瘤组1993例,肿瘤组129例。
  • 使用Student t检验比较两组诊疗一体化费用和结局,并用多元回归分析估计肿瘤相关手术与费用的关联。

主要发现

  • 肿瘤组住院时间显著更长(7.2 vs 4.2天,P = .00)。
  • 肿瘤组再入院比例更高(29% vs 14%,P = .05),出院至专业护理机构比例更高(93% vs 51%,P = .00)。
  • 肿瘤组住院指数费用(平均差1561美元,P = .05)、专业护理费用(平均差5932美元,P = .001)和总诊疗一体化费用(平均差20,012美元,P = .00)均更高。
  • 多因素分析显示,除年龄增长和骨折诊断外,肿瘤诊断与诊疗一体化费用增加独立相关(β = 16,163 ± 2258,P = .00,r2 = 29%)。

临床怎么用

  • 在髋关节置换诊疗一体化费用评估中,应考虑肿瘤性诊断带来的额外资源消耗和风险调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Comprehensive Care for Joint Replacement model aims to support more efficient care for patients. We examined the impact of patient and surgical characteristics, post-acute care, and clinical outcomes on episode of care (EOC) costs in patients undergoing hip arthroplasty for all diagnoses. METHODS: We retrospectively collected data from a large database of patients undergoing hip arthroplasty for oncologic and nononcologic diagnoses between 2014 and 2017. We compared EOC costs and outcomes between the 2 groups using Student's t-tests. We estimated the association between an oncologic-associated procedure and EOC costs from a multiple regression analysis. RESULTS: There were 2122 total patients included: 1993 in the nononcologic group and 129 in the oncologic group. The length of stay was significantly greater in the oncologic group (7.2 vs 4.2 days, P = .00). In the post-acute period, a greater proportion of oncologic patients was readmitted (29% vs 14%, P = .05) and discharged to skilled nursing (93% vs 51%, P = .00). Index hospitalization costs (mean difference [MD] $1561, P = .05), skilled nursing costs (MD $5932, P = .001), and total EOC costs (MD $20,012, P = .00) were all greater in the oncologic group. Along with increasing age and fracture diagnosis, an oncologic diagnosis is independently associated with greater EOC costs from a multivariate analysis (β = 16,163 ± 2258, P = .00, r2 = 29%). CONCLUSION: Comprehensive Care for Joint Replacement should incorporate risk adjustment for oncologic disease because hip arthroplasty for an oncologic diagnosis is associated with worse outcomes and greater costs than in the general population.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Gammal ID, Matuszak SJ, Kenan S, et al. To Bundle or Not to Bundle? The Financial Impact of Pathologic Hip Disease on Hip Arthroplasty Episodes of Care. J Arthroplasty. 2020. PMID: 32029349. doi:10.1016/j.arth.2020.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。